Health

Octapharma USA announces FDA approval of cutaquig 16





Octapharma USA today announced the U.S. Food & Drug Administration (FDA) has approved cutaquig® [Immune globulin, Subcutaneous (Human)-hipp, 16.5% Solution] for the treatment of pediatric patients age 2 and older with primary humoral immunodeficiency (PI). The FDA previously approved cutaquig® for adults with PI.

“The FDA approval provides physicians and families with more treatment options for patients with primary immune disorders, which weaken the immune system and can allow infections and other health issues to occur more easily,” said Roger H. Kobayashi, M.D., Clinical Professor UCLA School of Medicine and National Consultant, Immune Deficiency Foundation. “The FDA approval also provides more flexible options by permitting more frequent or less frequent infusions, which can be advantageous based on a patient’s pharmacokinetic and clinical response.”

Patients and providers have the flexibility to administer cutaquig® at a lower dose more frequently or at a larger dose less frequently if desired. Patients who prefer less frequent injections may have the option of receiving therapy every other week. At the same time, physicians can prescribe daily dosing if patients respond better to more frequent therapy.

Cutaquig® provides enhanced convenience for a wider group of patients who want to customize therapy with their prescriber to best match patient lifestyle needs,” said Octapharma USA President Flemming Nielsen. “Octapharma is committed to providing people with immune disorders the life-saving therapies they need. Both the addition of the pediatric indication and the flexible dosing illustrate our commitment to ensure patients have access to lifesaving products that offer a variety of choices for therapy delivery.”

Flemming Nielsen, President, Octapharma USA

The FDA approval of cutaquig® is based on the results of two clinical trials, which observed 75 PI patients, 37 adults and 38 pediatric patients between ages 2 and 17. The patients received weekly infusions with cutaquig® during a 12-week wash-in/wash-out period followed by a 12-month efficacy period. The main objective of the research was to assess the efficacy of cutaquig® in preventing serious bacterial infections, defined as bacteremia/sepsis, bacterial meningitis, osteomyelitis/septic arthritis, bacterial pneumonia and visceral abscess. No serious bacterial infections were reported.

Read The Full Article Here

The Lasting Impact of Sibling and Family Comparisons on Childhood and Adulthood
Overcoming the Inferiority Complex Among College Students
Barbie: Breaking Stereotypes and Embracing Creativity
Psychological Insights: Unraveling the Core of Challenging Children – Exploring their Formative Years
The Mysteries of Extended Breastfeeding: From Family Irritation to Mother-to-Mother Comparisons
Prince Harry Opens Up About When He Knew Meghan Markle
Rich Pregnant vs Broke Pregnant
How To Watch The Perseid Meteor Shower With Your Family
Baby Care Tips
How to Care a newborn kitten
Main Tota Hare Rang Ka
Drug Free Kids
The Oedipus Complex: Understanding its Dynamics, Development, and Potential Disruptions
The Lasting Impact of Sibling and Family Comparisons on Childhood and Adulthood
Barbie: Breaking Stereotypes and Embracing Creativity
The Importance of a Comfort Blanket for Children: A Crucial Psychological Comfort
The Profound Nexus of Dreams and Sleep Disturbances in Juveniles: A Comprehensive Psychological and Biological Analysis
The Mysteries of Extended Breastfeeding: From Family Irritation to Mother-to-Mother Comparisons
Addressing Nightmares with Your Child: A Step towards Alleviating Fears
Essential Items Every Mom Should Carry in Her Bag for Handling Minor Mishaps
Child Development: Are You Anxious About Autistic Risks?
Autism: Tools To Adapt Yourself To Your Child’s Emotions And Unexpressed Requests
Essential Items Every Mom Should Carry in Her Bag for Handling Minor Mishaps
Why You Should Take Your Kid to Charity Shops Even If You are Wealthy
Mindfulness with Your Kids
The Psychological Contents of Halloween